Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Atara Biotherapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($87.6M and $84.0M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against −96.7%. Atara Biotherapeutics, Inc. has the higher net margin (−269.4% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 15 metrics below, Atara Biotherapeutics, Inc. leads on 11 and Tonix Pharmaceuticals Holding Corp. on 4.

Valuation

Metric ATRA TNXP Biotechnology median
P/E n/m n/m 10.26
P/S 19.54 2.65 9.18
P/B n/m 0.35 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.56 0.65
EV/Sales 17.94 (3.15) 8.98
Earnings yield (14.66%) (278.89%) (34.89%)
Free cash flow yield (17.38%) (205.28%) (24.52%)

Profitability

Metric ATRA TNXP Biotechnology median
Gross margin 91.38% 83.83% 65.16%
Operating margin (229.67%) (568.43%) 0.00%
Net margin (269.42%) (548.64%) 0.00%
Free cash flow margin (353.49%) (543.29%) 0.00%
Return on equity 46.33% (81.82%) (50.12%)
Return on assets (57.62%) (72.34%) (45.60%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric ATRA TNXP Biotechnology median
Revenue growth (TTM) (96.72%) 196.02% 6.26%
EPS growth (last fiscal year) 122.52% 91.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 6.61 4.89
Net debt to EBITDA (0.22) 1.68 1.01

Dividend

Metric ATRA TNXP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATRA TNXP Biotechnology median
Market cap 84.02m 87.64m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack